Press release
Ascites Market Size is Set for Rapid Growth as Innovative Treatments and Rising Awareness Drive Demand by 2034
Ascites Market Size
[Nevada, United States] - DelveInsight's "Ascites Market Insights, Epidemiology, and Market Forecast 2034." report offers a detailed examination of Ascites, covering historical and predicted epidemiology, market trends, and treatment scenarios in the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom, and Japan.
To Know in detail about the Ascites Market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; https://www.delveinsight.com/report-store/ascites-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Key Findings from the Ascites Market Report:
The Ascites market size is poised for significant growth, with an anticipated Compound Annual Growth Rate (CAGR) during the study period (2020-2034).
In August, 2024: Versantis AG announced that a Phase 2, multi-center, randomized, controlled, open-label study to evaluate the effects of the intraperitoneal, liposomal formulation VS-01 in patients with an acute episode of hepatic and/or extrahepatic organ dysfunctions and failures in the presence of liver cirrhosis (Acute-on-Chronic Liver Failure, ACLF) and accumulation of fluid in the abdominal cavity (ascites)
In June, 2024: Grifols Therapeutics LLC announced that a phase 3, multicenter, randomized, controlled, parallel-group, and open-label clinical study to evaluate the efficacy of standard medical treatment (SMT) + Albutein 20% administration versus SMT alone in subjects with decompensated cirrhosis and ascites.
In June, 024: Noorik Biopharmaceuticals AG announced that the goal of this clinical trial is to test whether the administration of low doses of ambrisentan can help patients with Hepatorenal Syndrome and to determine if it is safe.
In May, 2024: Wuhan YZY Biopharma Co., Ltd. announced that their Phase 3 clinical study will Compare the Efficacy and Safety of Recombinant Anti-EpCAM and Anti-CD3 Human-Mouse Chimeric Bispecific Antibody (M701) for Intraperitoneal Injection to Paracentesis alone in Patients with Malignant Ascites Caused by Advanced Epithelial Solid Tumors.
In the 7MM, the total cases of Ascites due to cirrhosis in 2022 were 243,682. As per the estimates by DelveInsight, these cases are expected to increase at a substantial CAGR for the study period of 2020-2034.
In 2022, there were 151,474 number of Ascites due to cirrhosis in the United States. In 2022, the number of cases of ascites from ovarian, stomach, breast, and colorectal cancer in the United States were found to be 8,845 , 3,704 , 12,990 , and 10,632 respectively.
Assessments as per DelveInsight's analysts showed that there were 27,265 cases of Grade I ascites due to cirrhosis in the United States in 2022 which was nearly 22% of all grade ascites cases.
Key Ascites Companies are as follows: Ocelot Bio, PharmaIN, Genfit, NovaShunt AG, Wuhan YZY Biopharma Co., Ltd., Neovii Biotech, Protgen Ltd, Movetis, Sanofi, BioVie Inc., Versantis AG, Ocelot Bio, Inc, Mallinckrodt.
Key Ascites Therapies are as follow: PHIN-214, OCE-205, VS-01, M701, OrsHSA, Tolvaptan, catumaxomab, M0002, Albumin, satavaptan (SR121463B), Rifaximin, Tolvaptan, Prednisolone, Endostar, Cisplatin, OCE-205, Ambrisentan, Terlipressin.
Launching multiple stage Ascites pipeline products is expected to revolutionize market dynamics, further propelling market growth.
Dive into our detailed Ascites market research report to uncover actionable insights, industry forecasts, and competitive analysis @ https://www.delveinsight.com/sample-request/ascites-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Ascites Overview:
Ascites (hydroperitoneum is a rare synonym) is defined as an abnormal amount of intraperitoneal fluid. Ascites is a condition in which fluid collects in spaces within the abdomen. If severe, ascites may be painful. The problem may keep the patient from moving around comfortably. Ascites can set the stage for an infection in the abdomen. Fluid may also move into the chest and surround the lungs. This condition can make eating, drinking, and moving around difficult. It can also make it hard to breathe. Ascites can lead to abdominal infections, which may cause kidney failure and can also cause umbilical or inguinal hernias
Ascites Drugs Uptake and Pipeline Development Activities:
The drugs uptake section focuses on the rate of uptake of potential drugs recently launched or expected to be launched during the study period. The report covers market uptake by drugs, patient uptake by therapies, and sales of each drug. Additionally, it provides insights into Ascites Pipeline Development Activities, analyzing therapeutic candidates in various stages and key companies involved.
For more information about Ascites companies working in the treatment market: https://www.delveinsight.com/sample-request/ascites-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Ascites Therapies and Key Companies:
PHIN-214: PharmaIN
OCE-205: Ocelot Bio
VS-01: Genfit
M701: Wuhan YZY Biopharma Co., Ltd.
catumaxomab: Neovii Biotech
M0002, Placebo: Movetis
satavaptan (SR121463B): Sanofi
Terlipressin acetate continuous infusion: BioVie Inc.
Ascites Epidemiology:
The epidemiology section provides insights into historical, current, and forecasted trends in the seven major countries (7MM) from 2020 to 2034. It explores various studies and opinions to recognize the causes of current and forecasted trends. The segmentation includes total prevalence, severity-based prevalence, gender-specific prevalence, and diagnosed cases of episodic and chronic Ascites.
Seize Market Opportunities with Our Expert Analysis! Our report delivers valuable insights into market dynamics, key players, and emerging trends @ https://www.delveinsight.com/sample-request/ascites-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Ascites Epidemiology Segmentation:
The Ascites market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
Ascites Total Prevalence
Ascites Prevalent Cases by severity
Ascites Gender-specific Prevalence
Ascites Diagnosed Cases of Episodic and Chronic
Ascites Market Drivers:
Increasing Prevalence of Liver Diseases
Advances in Diagnostic Techniques
Growing Geriatric Population
Increased Awareness and Early Diagnosis
Ascites Market Barriers:
High Treatment Costs
Complications and Side Effects
Limited Treatment Options for Refractory Ascites
Lack of Awareness in Developing Regions
Stay Ahead in a Competitive Landscape with Our Exhaustive Market Research Report-Dive Into Detailed Analysis, Key Trends, and Future Projections @ https://www.delveinsight.com/sample-request/ascites-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Scope of the Ascites Market Report:
Study Period: 2020-2034
Coverage: 7MM (The United States, EU5, and Japan)
Key Ascites Companies: Ocelot Bio, PharmaIN, Genfit, NovaShunt AG, Wuhan YZY Biopharma Co., Ltd., Neovii Biotech, Protgen Ltd, Movetis, Sanofi, BioVie Inc., Versantis AG, Ocelot Bio, Inc, Mallinckrodt.
Key Ascites Therapies: PHIN-214, OCE-205, VS-01, M701, OrsHSA, Tolvaptan, catumaxomab, M0002, Albumin, satavaptan (SR121463B), Rifaximin, Tolvaptan, Prednisolone, Endostar, Cisplatin, OCE-205, Ambrisentan, Terlipressin.
Ascites Therapeutic Assessment: Current marketed and emerging therapies
Ascites Market Dynamics: Ascites Market drivers and Ascites barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
Ascites Unmet Needs: Insights into unmet needs, KOL's views, Analyst's views, Market Access, and Reimbursement.
To access the full report and gain a deeper understanding of Ascites market outlook, drug uptake, treatment scenario, and epidemiology trends: https://www.delveinsight.com/sample-request/ascites-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Table of Content:
1. Key Insights
2. Report Introduction
3. Executive Summary
4. Ascites Market Overview at a Glance
5 Key Events
6 Epidemiology and Market Forecast Methodology
7 Disease Background and Overview
8 Epidemiology and Patient Population
9 Patient Journey
10 Emerging Therapies
11 Ascites: Seven Major Market Analysis
12 Unmet Needs
13 SWOT Analysis
14 KOL Views
15 Market Access and Reimbursement
16 Appendix
17 DelveInsight Capabilities
18 Disclaimer
19 About DelveInsight
List of TOP Selling Inhibitors Market Research Report as of 2024:
CTLA-4 Inhibitors Market: https://www.delveinsight.com/report-store/ctla4-inhibitors-market-forecast
VEGF Inhibitors Market: https://www.delveinsight.com/report-store/vegf-inhibitors-market-forecast
TROP-2 Inhibitors Market: https://www.delveinsight.com/report-store/trop2-inhibitors-market-forecast
HER2+ Market: https://www.delveinsight.com/report-store/her2-positive-market-forecast
HER3+ Market: https://www.delveinsight.com/report-store/her3-positive-market-forecast
FTase Inhibitors Market: https://www.delveinsight.com/report-store/ftase-inhibitors-market-forecast
Bispecifics Market: https://www.delveinsight.com/report-store/bispecifics-market-forecast
CAR-T Market: https://www.delveinsight.com/report-store/car-t-market-forecast
CD-19 Market: https://www.delveinsight.com/report-store/cd19-market-forecast
CD-20 Market: https://www.delveinsight.com/report-store/cd20-market-forecast
CD-38 Market: https://www.delveinsight.com/report-store/cd38-market-forecast
TP-53 Market: https://www.delveinsight.com/report-store/tp53-market-forecast
NTRK Market: https://www.delveinsight.com/report-store/ntrk-market-forecast
BRCA Market: https://www.delveinsight.com/report-store/brca-market-forecast
SMAD4/DPC4 Market: https://www.delveinsight.com/report-store/smad4-dpc4-market-forecast
Connective Tissue Growth Factor (CTGF) Inhibitors Market: https://www.delveinsight.com/report-store/connective-tissue-growth-factor-ctgf-inhibitors-market-forecast
Selective Inhibitor of the CXCR4 Chemokine Receptor Market: https://www.delveinsight.com/report-store/selective-inhibitor-of-the-cxcr4-chemokine-receptor-market-forecast
PI3K Market: https://www.delveinsight.com/report-store/pi3k-market-forecast
FGFR Market: https://www.delveinsight.com/report-store/fgfr-market-forecast
PROTAC Market: https://www.delveinsight.com/report-store/protac-market-forecast
CEACAM5 Market: https://www.delveinsight.com/report-store/ceacam5-market-forecast
Anti Cancer Vaccine Market: https://www.delveinsight.com/report-store/anti-cancer-vaccine-market-forecast
Androgen Receptor Inhibitor Market: https://www.delveinsight.com/report-store/androgen-receptor-inhibitor-market-forecast
GnRH Receptor Antagonist Market: https://www.delveinsight.com/report-store/gnrh-receptor-antagonist-market-forecast
CDK4/6 Inhibitor Market: https://www.delveinsight.com/report-store/cdk4-6-inhibitor-market-forecast
SERD Market: https://www.delveinsight.com/report-store/serd-market-forecast
AKT Inhibitor Market: https://www.delveinsight.com/report-store/akt-inhibitor-market-forecast
Radioligand Therapies Market: https://www.delveinsight.com/report-store/radioligand-therapies-market-forecast
B7-H3 Market: https://www.delveinsight.com/report-store/b7-h3-market-forecast
CYP17 Inhibitor Market: https://www.delveinsight.com/report-store/cyp17-inhibitor-market-forecast
NTD AR Inhibitor Market: https://www.delveinsight.com/report-store/ntd-ar-inhibitor-market-forecast
NRG fusion Market: https://www.delveinsight.com/report-store/nrg-fusion-market-forecast
AXL Receptor Tyrosine Kinase Inhibitors Market: https://www.delveinsight.com/report-store/axl-receptor-tyrosine-kinase-inhibitors-market-forecast
PSMA-Targeted Therapy Market: https://www.delveinsight.com/report-store/psma-targeted-therapy-market-forecast
EGFR Market: https://www.delveinsight.com/report-store/egfr-market-forecast
ALK Market: https://www.delveinsight.com/report-store/alk-market-forecast
BRAF Market: https://www.delveinsight.com/report-store/braf-market-forecast
ERBB 2 Receptor Antagonists Market: https://www.delveinsight.com/report-store/erbb2-receptor-antagonists-market-forecast
VEGFR-2 Inhibitor Market: https://www.delveinsight.com/report-store/vegfr2-inhibitor-market-forecast
Thymidine Phosphorylase Inhibitors Market: https://www.delveinsight.com/report-store/thymidine-phosphorylase-inhibitors-market-forecast
DNA Synthesis Inhibitor Market: https://www.delveinsight.com/report-store/dna-synthesis-inhibitor-market-forecast
CD223 Antigen Inhibitors Market: https://www.delveinsight.com/report-store/cd223-antigen-inhibitors-market-forecast
BTK Inhibitors Market: https://www.delveinsight.com/report-store/btk-inhibitors-market-forecast
SERMS Market: https://www.delveinsight.com/report-store/serms-market-forecast
PLK1 Inhibitor Market: https://www.delveinsight.com/report-store/plk1-inhibitor-market-forecast
CD47 Antigen Inhibitors Market: https://www.delveinsight.com/report-store/cd47-antigen-inhibitors-market-forecast
RET Fusion Market: https://www.delveinsight.com/report-store/ret-fusion-market-forecast
ROS-1 Market: https://www.delveinsight.com/report-store/ros1-market-forecast
Mesenchymal-epithelial Transition Factor (MET) Market: https://www.delveinsight.com/report-store/mesenchymal-epithelial-transition-factor-met-market-forecast
MET Kinase Inhibitor Market: https://www.delveinsight.com/report-store/met-kinase-inhibitor-market-forecast
About DelveInsight
DelveInsight is a leading market research firm providing insightful solutions and services to pharmaceutical and life sciences companies. With a commitment to delivering accurate and comprehensive reports, DelveInsight empowers businesses to make informed decisions and navigate the complexities of the healthcare industry.
Contact Information:
Company Name: DelveInsight Business Research LLP
Contact Person: Ram Kapoor
Email: info@delveinsight.com
Contact No.: +91-9650213330
City: 304 S. Jones Blvd #2432, Las Vegas
State: Nevada (89107)
Country: United States
Website: https://www.delveinsight.com/consulting
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ascites Market Size is Set for Rapid Growth as Innovative Treatments and Rising Awareness Drive Demand by 2034 here
News-ID: 3655381 • Views: …
More Releases from DelveInsight Business Research LLP
Oral Mucositis Pipeline Insights, Treatment Drugs, Clinical Trials, and Companie …
(Albany, United States) As per DelveInsight's assessment, globally, the Oral Mucositis Pipeline constitutes 10+ Oral Mucositis companies continuously working towards developing 10+ Oral Mucositis Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight.
To explore more information on the latest breakthroughs in the Oral Mucositis Pipeline treatment landscape of the report, click here @ Oral Mucositis Pipeline Outlook- https://www.delveinsight.com/report-store/oral-mucositis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the…
Alpha-1 Antitrypsin Deficiency Pipeline Insight, Treatment Drugs, Clinical Trial …
DelveInsight's, "Alpha1-Antitrypsin Deficiency Pipeline Insight 2024" report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in the Alpha1-Antitrypsin Deficiency pipeline landscape. It covers the Alpha-1 Antitrypsin Deficiency pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Alpha-1 Antitrypsin Deficiency pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Request a sample…
Constipation Pipeline Insights, Treatment Drugs, Clinical Trials, and Companies …
DelveInsight's, "Constipation Pipeline Insight 2024" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Constipation pipeline landscape. It covers the Constipation pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Constipation pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Request a sample and discover the recent advances in…
Cirrhosis Pipeline Insights, Clinical Trials, Treatment Drugs, and Companies 202 …
DelveInsight's, "Cirrhosis Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Cirrhosis pipeline landscape. It covers the Cirrhosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Request a sample and discover the recent advances in Cirrhosis Treatment…
More Releases for Market:
India Tractor Market, Tractor Industry, Market Revenue, Market Growth Analysis, …
How Is India Tractor Market Positioned?
In India two-third population is engaged in Agriculture. Tractors form an essential part of this sector. They bring the required efficiency and productivity country needs in its agricultural activity to compete on the international level. The Indian tractor Industry has made preponderant improvement in production capacity and in terms of production volumes. The industry has been successful in indigenization of the technology. The volume growth…
Global Optical Interconnects Market, Market Size, Market Shares, Market Growth A …
In integrated circuits, optical interconnects majorly refers to a system of transmitting signals from one fragment of an integrated circuit to another part which is using light. Optical interconnects have been in high demand due to the high latency and power consumption incurred by conventional metal interconnects in conveying electrical signals over long distances, such as in interconnects classed as global interconnects.
The International Technology Roadmap for Semiconductors (ITRS) has emphasized…
Global Cash Registers Market, Market Growth Analysis, Market Revenue, Market Out …
A cash register or automatic money handling system is a motorized or electric device for registration and calculating dealings at a point of sale. It is typically devoted to a drawer for storage cash and additional valuables. A modern cash register is generally attached to a printer which can print out incomes for record-keeping determinations. The electronics cash register delivers numerous features likes mall price and informal admittance. The rising acceptance of electronic cash register by…
Global Organic Food & Beverage Market | Market Size, Market Share, Market Trends …
The term 'organic' has gained much popularity since the last decade, which refers to the process of how certain foods are produced. Organic food is grown without the use of synthetic chemicals, such as human-made pesticides and fertilizers, and does not contain genetically modified organisms (GMOs). According to the recently published report titled, 'Global Organic Food & Beverage Outlook, 2026', by Bonafide Research the organic foods & beverage industry has…
Robotic Cardiology Surgery Market Insights Includes Market Share, Market Researc …
Robotic Cardiology Surgery Market
Global demand for cardiac surgery robots in 2025 will explode to $XXX billion. This represents an astonishing XX% growth yearly in terms of annual revenue between 2016 and 2025, and a cumulative market total of $7.50 billion during 2017-2025 owing to the substantial increase of robot-based and computer-assisted cardiological surgery procedures for heart disorders.
Global Robotic Cardiology Surgery Market 2016-2025: Market Size, Share, Forecast and Strategy is based…
Educational Robots Market, Market Segmentation, Market Report, Market Forecast
Global Educational Robots market valued USD 670 Million in 2017 and is likely to grow more than USD 2339.8 Million by 2025 with a compounded annual growth of 16.92% over the forecast period 2018-2025. The market growth is primarily driven by technological enhancements in the field of robotics and increasing use of robots for educational purposes. However, high initial research and development expenses hamper market growth. The main function of…
